Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy

This drug review presents a comprehensive review of Cariprazine, a medication that received FDA approval in 2015 for treating schizophrenia and bipolar disorder. The paper begins by exploring Cariprazine's mechanism of action, which involves modulating dopamine and serotonin receptors. Addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarzian, Martin, Ndrio, Mariana, Kaja, Srujan, Beason, Elisabeth, Fakoya, Adegbenro O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292137/
https://www.ncbi.nlm.nih.gov/pubmed/37378203
http://dx.doi.org/10.7759/cureus.39309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292137/
https://www.ncbi.nlm.nih.gov/pubmed/37378203
http://dx.doi.org/10.7759/cureus.39309

Ejemplares similares